The domestically-made cervical cancer vaccine is listed at only half of the imported adults and only costs about 1,000 yuan for the entire injection.

The domestic bivalent vaccine for cervical cancer started its first injection in Beijing last week.

Currently, there are two types of bivalent cervical cancer vaccines on the market in my country: imported and domestically produced.

Advantage 1: The price is half cheaper

It is understood that the price of imported HPV vaccines is generally high.

Advantage two: shorten the course of vaccination

The manufacturer of this domestic HPV vaccine is Xiamen Wantai Canghai Biotechnology Co.

Advantage three: young people can be vaccinated

At present, the applicable age for the bivalent HPV vaccine marketed in China is 9 to 45 years old; the applicable population for the nine-valent HPV vaccine is 16-26 years old women; the applicable age for the quadrivalent HPV vaccine is 20 to 45 years old.

On December 31, 2019, the National Medical Products Administration issued an announcement stating that the approved bivalent human papillomavirus vaccine (E.

It is understood that the vaccine is my country’s first cervical cancer vaccine independently developed by Wantai Company and Xiamen University and transformed by Wantai.

prompt

Both bivalent and quadrivalent vaccines can defend

The two most dangerous precancerous lesions

Cervical cancer vaccine, also known as HPV vaccine, is a vaccine to prevent the onset of cervical cancer.

At present, domestic cervical cancer vaccines include imported bivalent, quadrivalent, and quaternary vaccines and domestic bivalent vaccines.

It should be noted that yesterday afternoon, a reporter from the Beijing Youth Daily called a community health center in Beijing to inquire about domestic cervical cancer vaccine injections.